We are pleased to announce that Dr. Ambereen Mehta will be the next medical director of the Palliative Care Program at Johns Hopkins Bayview Medical Center (JHBMC).
Dr. Mehta is an associate professor in the Division of General Internal Medicine at JHBMC and president-elect of the International Neuropalliative Care Society where she also serves as chair of the Governance Committee.
After completing an internal medicine residency at JHBMC and a fellowship in hospice and palliative medicine at the NIH, Dr. Mehta joined the palliative care faculty at the University of Virginia, where she served as medical director of the UVA/Hospice of the Piedmont Inpatient Hospice Unit and associate program director of their Hospice and Palliative Medicine Fellowship. She then joined the faculty at the University of California, Los Angeles, where she started the amyotrophic lateral sclerosis (ALS) palliative care program. In 2020, she came to Hopkins to join the palliative care faculty at JHBMC and is now the only palliative care expert in the Johns Hopkins Center for ALS Specialty Care.
She leads multiple studies as part of the ALS Clinical Trials Unit and has published numerous studies on increasing access to specialty palliative care, including education for neurologists and improving quality of life for people with neurological illnesses, specifically those living with ALS. In 2024, Dr. Mehta and Dr. Albert Garcia-Romeu, Associate Professor of Psychiatry and Behavioral Sciences, were awarded more than $2 million by the Department of Defense to lead a clinical trial for patients with ALS to study the effects of psilocybin on mood, hopelessness, and quality of life.
As medical director of the Palliative Care Program at JHBMC, Dr. Ambereen Mehta will work with Dr. Scott Wright, director of the Division of General Internal Medicine at JHBMC, to continue the success of the program. Please join us in congratulating her on her new role.
